{"title":"有关 Mpox 的药物发现、诊断和治疗趋势：专利概况","authors":"Rohit Sharma , Ruchi Sharma , Rajeev K. Singla","doi":"10.1016/j.crbiot.2023.100173","DOIUrl":null,"url":null,"abstract":"<div><p>As of early 2022, Mpox has resurged and expanded globally, posing a new threat to global health. In close to 110 countries, 87,000 confirmed cases and 112 deaths have been reported as on April 18, 2023. Considering the current pandemic crisis and future developments, it is imperative to understand and characterize the global patent scenario of Mpox. In biological sciences, patents are often promising indicators of technological knowledge production. This patent landscape analysis is the first to provide a solid intellectual foundation for the ongoing development of diagnostic measures, therapeutic drug agents, and vaccines for Mpox. Our search encompassed several patent databases to identify patents related to Mpox, including PatSeer, Google patents, <span>lens.org</span><svg><path></path></svg>, Espacenet, and Patentscope. Patenting trends are discussed, and a Whitespace analysis is carried out in this paper, suggesting the knowledge gaps and promising areas for future research on Mpox. This study could serve as an epicentre for provoking ideas and mitigation strategies.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262823000552/pdfft?md5=77dcdf1dcbd7b09e2657ea1325206c5f&pid=1-s2.0-S2590262823000552-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Drug Discovery, Diagnostic, and therapeutic trends on Mpox: A patent landscape\",\"authors\":\"Rohit Sharma , Ruchi Sharma , Rajeev K. Singla\",\"doi\":\"10.1016/j.crbiot.2023.100173\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>As of early 2022, Mpox has resurged and expanded globally, posing a new threat to global health. In close to 110 countries, 87,000 confirmed cases and 112 deaths have been reported as on April 18, 2023. Considering the current pandemic crisis and future developments, it is imperative to understand and characterize the global patent scenario of Mpox. In biological sciences, patents are often promising indicators of technological knowledge production. This patent landscape analysis is the first to provide a solid intellectual foundation for the ongoing development of diagnostic measures, therapeutic drug agents, and vaccines for Mpox. Our search encompassed several patent databases to identify patents related to Mpox, including PatSeer, Google patents, <span>lens.org</span><svg><path></path></svg>, Espacenet, and Patentscope. Patenting trends are discussed, and a Whitespace analysis is carried out in this paper, suggesting the knowledge gaps and promising areas for future research on Mpox. This study could serve as an epicentre for provoking ideas and mitigation strategies.</p></div>\",\"PeriodicalId\":52676,\"journal\":{\"name\":\"Current Research in Biotechnology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590262823000552/pdfft?md5=77dcdf1dcbd7b09e2657ea1325206c5f&pid=1-s2.0-S2590262823000552-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Research in Biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590262823000552\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590262823000552","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Drug Discovery, Diagnostic, and therapeutic trends on Mpox: A patent landscape
As of early 2022, Mpox has resurged and expanded globally, posing a new threat to global health. In close to 110 countries, 87,000 confirmed cases and 112 deaths have been reported as on April 18, 2023. Considering the current pandemic crisis and future developments, it is imperative to understand and characterize the global patent scenario of Mpox. In biological sciences, patents are often promising indicators of technological knowledge production. This patent landscape analysis is the first to provide a solid intellectual foundation for the ongoing development of diagnostic measures, therapeutic drug agents, and vaccines for Mpox. Our search encompassed several patent databases to identify patents related to Mpox, including PatSeer, Google patents, lens.org, Espacenet, and Patentscope. Patenting trends are discussed, and a Whitespace analysis is carried out in this paper, suggesting the knowledge gaps and promising areas for future research on Mpox. This study could serve as an epicentre for provoking ideas and mitigation strategies.
期刊介绍：
Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines.
Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
